Estelle Li

917 total citations
11 papers, 311 citations indexed

About

Estelle Li is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Estelle Li has authored 11 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Estelle Li's work include Bladder and Urothelial Cancer Treatments (3 papers), Epigenetics and DNA Methylation (3 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Estelle Li is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Epigenetics and DNA Methylation (3 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Estelle Li collaborates with scholars based in Canada, Australia and Germany. Estelle Li's co-authors include Ladan Fazli, Martin Gleave, Colleen C. Nelson, Melanie Lehman, John E.J. Rasko, Jeff Holst, William Ritchie, Qian Wang, Cynthia Metierre and Yue Feng and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Estelle Li

11 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Estelle Li Canada 6 195 78 76 69 68 11 311
Dimitris Karagiannis United States 8 376 1.9× 116 1.5× 116 1.5× 22 0.3× 52 0.8× 8 474
Sunsook Hwang South Korea 10 187 1.0× 91 1.2× 169 2.2× 24 0.3× 41 0.6× 15 367
Laura Ghisolfi United States 7 219 1.1× 163 2.1× 115 1.5× 31 0.4× 37 0.5× 10 356
Nicla Lorito Italy 9 199 1.0× 71 0.9× 193 2.5× 36 0.5× 87 1.3× 11 347
Valérie Vial France 8 205 1.1× 68 0.9× 147 1.9× 61 0.9× 46 0.7× 14 332
Brendah K. Masisi United Kingdom 9 229 1.2× 69 0.9× 181 2.4× 48 0.7× 68 1.0× 12 324
Michael D. Arensman United States 5 227 1.2× 93 1.2× 115 1.5× 25 0.4× 68 1.0× 8 332
Sarah Neidler United Kingdom 3 200 1.0× 59 0.8× 152 2.0× 39 0.6× 36 0.5× 3 271
Nadia Vié France 7 201 1.0× 164 2.1× 105 1.4× 22 0.3× 54 0.8× 10 362

Countries citing papers authored by Estelle Li

Since Specialization
Citations

This map shows the geographic impact of Estelle Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estelle Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estelle Li more than expected).

Fields of papers citing papers by Estelle Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estelle Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estelle Li. The network helps show where Estelle Li may publish in the future.

Co-authorship network of co-authors of Estelle Li

This figure shows the co-authorship network connecting the top 25 collaborators of Estelle Li. A scholar is included among the top collaborators of Estelle Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estelle Li. Estelle Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Estelle, et al.. (2020). An Empirical Study on Cross-Border Profit Shifting in Australia. 3 indexed citations
2.
Li, Estelle, et al.. (2019). The Australian Dividend Imputation System and Corporate Tax Avoidance. 1 indexed citations
3.
Jäger, Wolfgang, Hui Xue, Tetsutaro Hayashi, et al.. (2015). Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. Oncotarget. 6(25). 21522–21532. 34 indexed citations
4.
Yu, Yue, Ning Xie, Estelle Li, et al.. (2014). Prostate Stromal Cells Express the Progesterone Receptor to Control Cancer Cell Mobility. PLoS ONE. 9(3). e92714–e92714. 33 indexed citations
5.
Jäger, Wolfgang, Christian Thomas, Ladan Fazli, et al.. (2014). DHH is an Independent Prognosticator of Oncologic Outcome of Clear Cell Renal Cell Carcinoma. The Journal of Urology. 192(6). 1842–1848. 16 indexed citations
6.
Xie, Yingqiu, Wenfu Lu, Qing Yang, et al.. (2014). Crosstalk Between Nuclear MET and SOX9/β-Catenin Correlates with Castration-Resistant Prostate Cancer. Molecular Endocrinology. 28(10). 1629–1639. 37 indexed citations
7.
Wang, Qian, Jessamy Tiffen, Charles G. Bailey, et al.. (2013). Targeting Amino Acid Transport in Metastatic Castration-Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development. JNCI Journal of the National Cancer Institute. 105(19). 1463–1473. 141 indexed citations
8.
Jäger, Wolfgang, Igor Moskalev, Tetsutaro Hayashi, et al.. (2013). Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach. PLoS ONE. 8(3). e59536–e59536. 42 indexed citations
9.
Hayashi, Tetsutaro, Kilian M. Gust, Wolfgang Jäeger, et al.. (2013). 594 SPECIFIC INHIBITON OF NOTCH-2 AS A NOVEL THERAPY FOR INVASIVE BLADDER CANCER. The Journal of Urology. 189(4S). 2 indexed citations
10.
Han, Kyung Seok, Na Li, Peter A. Raven, et al.. (2013). ER stress protein GRP78 as a therapeutic target combined with antiangiogenic therapy in renal cell carcinoma.. Journal of Clinical Oncology. 31(6_suppl). 428–428. 1 indexed citations
11.
Hayashi, Tetsutaro, Kilian M. Gust, Wolfgang Jäeger, et al.. (2013). Antineoplastic effects of specific inhibition of Notch-2 in bladder cancer.. Journal of Clinical Oncology. 31(15_suppl). e15590–e15590. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026